- Home
- AMTX vs BDTX Comparison
AMTX vs BDTX Comparison
Compare AMTX & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTX
- BDTX
- Stock Information
- Founded
- AMTX 2005
- BDTX 2014
- Country
- AMTX United States
- BDTX United States
- Employees
- AMTX N/A
- BDTX N/A
- Industry
- AMTX Major Chemicals
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMTX Industrials
- BDTX Health Care
- Exchange
- AMTX Nasdaq
- BDTX Nasdaq
- Market Cap
- AMTX 125.1M
- BDTX 132.5M
- IPO Year
- AMTX N/A
- BDTX 2020
- Fundamental
- Price
- AMTX $2.94
- BDTX $2.87
- Analyst Decision
- AMTX Strong Buy
- BDTX Strong Buy
- Analyst Count
- AMTX 4
- BDTX 6
- Target Price
- AMTX $13.63
- BDTX $14.83
- AVG Volume (30 Days)
- AMTX 1.5M
- BDTX 1.2M
- Earning Date
- AMTX 07-31-2025
- BDTX 08-05-2025
- Dividend Yield
- AMTX N/A
- BDTX N/A
- EPS Growth
- AMTX N/A
- BDTX N/A
- EPS
- AMTX N/A
- BDTX 0.09
- Revenue
- AMTX $237,892,000.00
- BDTX $70,000,000.00
- Revenue This Year
- AMTX $27.78
- BDTX N/A
- Revenue Next Year
- AMTX $91.59
- BDTX N/A
- P/E Ratio
- AMTX N/A
- BDTX $32.58
- Revenue Growth
- AMTX N/A
- BDTX N/A
- 52 Week Low
- AMTX $1.22
- BDTX $1.20
- 52 Week High
- AMTX $4.73
- BDTX $6.75
- Technical
- Relative Strength Index (RSI)
- AMTX 78.87
- BDTX 68.91
- Support Level
- AMTX $2.03
- BDTX $2.43
- Resistance Level
- AMTX $3.66
- BDTX $2.72
- Average True Range (ATR)
- AMTX 0.21
- BDTX 0.18
- MACD
- AMTX 0.10
- BDTX 0.02
- Stochastic Oscillator
- AMTX 80.37
- BDTX 99.31
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.